Screener
Cogent Biosciences, Inc. COGT Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 8:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205170
FAQ
- What is Cogent Biosciences, Inc.'s shares (diluted)?
- Cogent Biosciences, Inc. (COGT) reported shares (diluted) of 162.2M in Q1 2026.
- How has Cogent Biosciences, Inc.'s shares (diluted) changed year-over-year?
- Cogent Biosciences, Inc.'s shares (diluted) increased by 43.1% year-over-year, from 113.3M to 162.2M.
- What is the long-term trend for Cogent Biosciences, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s shares (diluted) has grown at a 34.3% compound annual growth rate (CAGR), from 151.9M to 494.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Cogent Biosciences, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude